2.6947 USD
+0.18 (+7.36%)
ChartMill assigns a Buy % Consensus number of 84% to ACRS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.16. This target is 202.82% above the current price.
ACRS was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ACRS.
In the previous month the buy percentage consensus was at a similar level.
ACRS was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-28 | Wedbush | Initiate | Outperform |
| 2025-05-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-09 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-03-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2024-12-23 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2024-11-19 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-11-19 | BTIG | Upgrade | Neutral -> Buy |
| 2024-11-19 | Jefferies | Upgrade | Hold -> Buy |
| 2024-11-18 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-19 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-07-22 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-01-22 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-01-11 | BTIG | Downgrade | Buy -> Neutral |
| 2023-12-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-18 | Stifel | Maintains | Hold -> Hold |
| 2023-11-14 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-13 | William Blair | Downgrade | Outperform -> Market Perform |
| 2023-11-13 | Stifel | Downgrade | Buy -> Hold |
| 2023-10-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-10-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-03 | Evercore ISI Group | Initiate | Outperform |
| 2023-09-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-14 | Stifel | Maintains | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
ACLARIS THERAPEUTICS INC / ACRS FAQ
Can you provide the average price target for ACLARIS THERAPEUTICS INC stock?
14 analysts have analysed ACRS and the average price target is 8.16 USD. This implies a price increase of 202.82% is expected in the next year compared to the current price of 2.6947.
Can you provide the consensus rating for ACLARIS THERAPEUTICS INC stock?
The consensus rating for ACLARIS THERAPEUTICS INC (ACRS) is 84.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ACRS stock?
The number of analysts covering ACLARIS THERAPEUTICS INC (ACRS) is 14.